Chapter
Saul Snyder's Hunt for Rapamycin
16:59 - 24:12 (07:13)
Saul Snyder, a pharmacologist, would scour literature for potent drug molecules and request for samples, ultimately leading to the discovery of Rapa Mison which displayed remarkable anti-proliferative properties and was approved by FDA for the treatment of kidney rejection.
Clips
Saren approached his new bosses at Wyeth and introduced his compound, Rapa Mison, which had anti-proliferative properties and was potent against T cells.
16:59 - 21:05 (04:06)
Summary
Saren approached his new bosses at Wyeth and introduced his compound, Rapa Mison, which had anti-proliferative properties and was potent against T cells. Wyeth could only get a use patent for the drug since the chemical entity's patent had expired, which led to criticism from people.
ChapterSaul Snyder's Hunt for Rapamycin
Episode#193: My Life Extension Pilgrimage to Easter Island
PodcastThe Tim Ferriss Show
The speaker talks about the importance of having a social environment in the lab and recalls a time when they were working with FK-506, a drug with structural similarities to rapamycin, in a lab where many students shared a work hard, play hard mentality.
21:05 - 22:28 (01:23)
Summary
The speaker talks about the importance of having a social environment in the lab and recalls a time when they were working with FK-506, a drug with structural similarities to rapamycin, in a lab where many students shared a work hard, play hard mentality.
ChapterSaul Snyder's Hunt for Rapamycin
Episode#193: My Life Extension Pilgrimage to Easter Island
PodcastThe Tim Ferriss Show
Saul Snyder, a pharmacologist, was fascinated by potent drug molecules like rapamycin and would write to whoever reported it to request a sample.
22:28 - 24:12 (01:44)
Summary
Saul Snyder, a pharmacologist, was fascinated by potent drug molecules like rapamycin and would write to whoever reported it to request a sample. His enthusiasm for rapamycin was reignited when he received a book of its bibliography, fueling his interest in the molecule once again.